Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rothenfusser

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Human Immunology|December 14, 2002
Plasmacytoid dendritic cells: the key to CpGSimon Rothenfusser, Evelyn Tuma, Stefan Endres, et al.
Current Opinion in Molecular Therapeutics|May 30, 2003
Recent advances in immunostimulatory CpG oligonucleotidesSimon Rothenfusser, Evelyn Tuma, Moritz Wagner, et al.
Cellular Immunology|July 27, 2002
Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytesSimon Rothenfusser, Armin Buchwald, Sylvia Kock, et al.
The Review of Scientific Instruments|July 5, 2013
Fusion of visual and infrared thermography images for advanced assessment in non-destructive testingK Eisler, C Homma, M Goldammer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1974
[Fructose-induced decrease of 2,3-diphosphoglycerate (2,3-DPG) in human erythrocytes: significance of blood pH]E Standl, H J Kolb, B Rothenfusser, et al.
Journal of the Neurological Sciences|October 10, 2017
Educational attainment and motor burden in advanced Parkinson's disease - The emerging role of education in motor reserveJosefine Blume, Eva Rothenfusser, Jürgen Schlaier, et al.
Microbes and Infection|May 9, 2000
Role of gammadelta T cells in tumor immunity and their control by NK receptorsA Moris, S Rothenfusser, E Meuer, et al.
Deutsches Arzteblatt International|December 16, 2015
Immunotherapy in TumorsSebastian Kobold, Peter Duewell, Max Schnurr, et al.
Advances in Neurology|January 1, 1980
Brain edema factors: current state with particular reference to plasma constituents and glutamateA Baethmann, W Oettinger, W Rothenfusser, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 11, 2019
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiencyClemens Küpper, Johanna Heinrich, Katharina Kamm, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Human Immunology|December 14, 2002
Plasmacytoid dendritic cells: the key to CpGSimon Rothenfusser, Evelyn Tuma, Stefan Endres, et al.
Current Opinion in Molecular Therapeutics|May 30, 2003
Recent advances in immunostimulatory CpG oligonucleotidesSimon Rothenfusser, Evelyn Tuma, Moritz Wagner, et al.
Cellular Immunology|July 27, 2002
Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytesSimon Rothenfusser, Armin Buchwald, Sylvia Kock, et al.
The Review of Scientific Instruments|July 5, 2013
Fusion of visual and infrared thermography images for advanced assessment in non-destructive testingK Eisler, C Homma, M Goldammer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1974
[Fructose-induced decrease of 2,3-diphosphoglycerate (2,3-DPG) in human erythrocytes: significance of blood pH]E Standl, H J Kolb, B Rothenfusser, et al.
Journal of the Neurological Sciences|October 10, 2017
Educational attainment and motor burden in advanced Parkinson's disease - The emerging role of education in motor reserveJosefine Blume, Eva Rothenfusser, Jürgen Schlaier, et al.
Microbes and Infection|May 9, 2000
Role of gammadelta T cells in tumor immunity and their control by NK receptorsA Moris, S Rothenfusser, E Meuer, et al.
Deutsches Arzteblatt International|December 16, 2015
Immunotherapy in TumorsSebastian Kobold, Peter Duewell, Max Schnurr, et al.
Advances in Neurology|January 1, 1980
Brain edema factors: current state with particular reference to plasma constituents and glutamateA Baethmann, W Oettinger, W Rothenfusser, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 11, 2019
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiencyClemens Küpper, Johanna Heinrich, Katharina Kamm, et al.
Pageof 10